Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:02 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 107.15 USD | +1.28% |
|
+4.91% | +25.69% |
| Nov. 12 | Daiwa Securities Adjusts Price Target on Edwards Lifesciences to $120 From $98 | MT |
| Nov. 12 | Analyst recommendations: Mastercard, Nvidia, Flex, Ge Aerospace… |  |
| Market Cap | 61.61B 55.83B 51.64B 46.59B 87.81B 5,809B 90.9B 620B 246B 3,103B 231B 226B 9,850B | P/E 2026 * |
46.2x | P/E 2027 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 58.11B 52.66B 48.71B 43.95B 82.82B 5,479B 85.74B 585B 232B 2,927B 218B 213B 9,291B | EV / Sales 2026 * |
8.53x | EV / Sales 2027 * | 7.56x |
| Free-Float |
86.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.28% | ||
| 1 week | +4.91% | ||
| Current month | +16.45% | ||
| 1 month | +23.94% | ||
| 3 months | +16.98% | ||
| 6 months | +31.73% | ||
| Current year | +25.69% |
| 1 week | 102.17 |  | 107.69 |
| 1 month | 86.08 | | 107.69 |
| Current year | 74.66 | | 107.69 |
| 1 year | 74.66 | | 107.69 |
| 3 years | 58.93 | | 107.69 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.28% | +4.91% | +24.16% | +62.87% | 61.61B | |
| +0.11% | +0.79% | +21.00% | +52.47% | 259B | |
| +0.37% | +1.20% | +5.34% | +14.49% | 164B | |
| +0.84% | -2.03% | -19.28% | +52.11% | 154B | |
| +0.32% | +3.72% | -56.82% | -17.92% | 64.27B | |
| +0.34% | -1.59% | +0.18% | -11.25% | 53.94B | |
| +0.55% | -0.46% | +18.49% | +55.86% | 49.04B | |
| -0.29% | -0.72% | +2.78% | +73.84% | 48.82B | |
| -0.42% | +0.58% | +21.31% | +77.93% | 45.24B | |
| +1.44% | +0.78% | +13.49% | +14.97% | 37.54B | |
| Average | +0.45% | +0.72% | +3.07% | +37.54% | 94B | |
| Weighted average by Cap. | +0.41% | +0.58% | +3.97% | +38.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.81B 6.17B 5.71B 5.15B 9.71B 642B 10.05B 68.57B 27.19B 343B 25.56B 25.01B 1,089B | 7.48B 6.78B 6.27B 5.66B 10.66B 705B 11.04B 75.31B 29.86B 377B 28.07B 27.47B 1,196B |
| Net income | 1.34B 1.22B 1.13B 1.02B 1.92B 127B 1.98B 13.54B 5.37B 67.73B 5.05B 4.94B 215B | 1.86B 1.68B 1.56B 1.4B 2.65B 175B 2.74B 18.7B 7.41B 93.52B 6.97B 6.82B 297B |
| Net Debt | -3.5B -3.17B -2.93B -2.65B -4.99B -330B -5.16B -35.25B -13.98B -176B -13.14B -12.86B -560B | -5.08B -4.6B -4.25B -3.84B -7.23B -479B -7.49B -51.1B -20.26B -256B -19.05B -18.64B -811B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | $107.15 | +1.28% | 3,822,379 |
| 26-11-12 | $105.80 | -0.01% | 4,178,650 |
| 26-11-11 | $105.81 | +1.73% | 4,252,321 |
| 26-11-10 | $104.01 | -0.67% | 3,777,302 |
| 26-11-09 | $104.71 | +2.52% | 6,683,074 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
